The invention discloses a Chinese medicinal composition for treating hepatofibrosis, which is mainly prepared from the following main raw materials: 10-20g of
trionyx sinensis shell, 10-20g of
tortoise shell, 9-15g of
curcuma zedoary, 12-15g of rhizoma sparganii, 18-25g of black sesame seeds, 15-18g of glossy
privet fruit and 30g of dry loach
powder. The following raw materials of the Chinese medicinal composition can be added selectively to treat the I-type symptoms of hepatofibrosis: 6-12g of fructus aurantii, 10g of coked malt, 10g of coked hawthorn, 10g of coked medicated leaven, and in addition, 12-18g of oriental wormwood and 10-15g of cape jasmine can be added to treat internal dampness and heat and
jaundice. The following raw materials of the Chinese medicinal composition can be added selectively to treat the II-type symptoms of hepatofibrosis: 20-30g of
dandelion, 6-9g of pseudo-
ginseng, 6-9g of red peony root, 8-12g of
curcuma aromatica, and in addition, 6-9g of hairyvein agrimony and 9-12g of
eclipta alba can be added to treat hemorrhage. The following raw materials of the Chinese medicinal composition can be added selectively to treat the III-type symptoms of hepatofibrosis: 12-18g of
codonopsis pilosula, 8-10g of dogwood and 9-12g of caulis spatholobi. 9-15g of subprostrate
sophora and 1.5g of
cordyceps sinensis can be added and decocted together with the raw materials to treat the positive marker of
hepatitis B
virus. The Chinese medicinal composition has a significant effect on 502 patients (69.05%) of the total 727 patients with the hepatofibrosis, is effective to 189 patients (26.00%), and is invalid to 36 patients (4.95%), thereby having the total effective rate of 95.05%.